RESEARCH

Monthly research. One thesis per theme.

Start with a trend — drones, uranium, defense, biotech — and get the small-caps scored for financial stability, not hype. Refreshed monthly.

FILTERED: HEALTHCARE
All2026AIAI CapexAI HardwareAdditive ManufacturingAdvanced ReactorsAerospaceAerospace & DefenseBatteryBeginnerBiotechCash RunwayChinaConsumer CyclicalCoolingCritical MineralsCryptoCybersecurityData AnalysisData CenterDeep DiveDefenseDroneDronesDrug DiscoveryETFsEdge AIEdge ComputingEducationEnergyEnergy TransitionFiberFuel CellsFundamental AnalysisGenomicsGovernanceGridGrowth StocksHALEUHVACHealthcareHow-ToHumanoidHydrogenIndustrialsInfrastructureIoTJune 2026LiDARLithiumMRAMMarket AnalysisMay 2026Medical DevicesMental HealthMetricsMonthly UpdateNPUNuclearOptical InterconnectPhotonicsPortfolio ManagementPortfolio StrategyPowerPre-RevenuePsychedelicsQ2 2026QuantumRankingsRisk ManagementRoboticsSMRSatelliteScore AnalysisScore DistributionScoring SystemSector AnalysisSemiconductorsSensorService RoboticsSmall-CapSoftwareSolarSpaceStock AnalysisStock PicksStrategySurgical RoboticsSwitchgearSynthetic BiologyTechTechnologyUAVUraniumUtilitiesValuationaerospaceaiai infrastructureapril 2026automationbiotechconsumercritical mineralsdefenseeVTOLearningseducationenergyfda approvalfundamental analysisgoldguidehealthcareindustrialsinvestinglithiummethodologymetricsminingnuclearquarterlyrare earthrevenue growthroboticsscoringsector analysissemiconductorssmall-capstock analysisstock pickstechnologyuraniumvaluationwatchlistweekly
SHOWINGHealthcareClear

FILTERED POSTS

BiotechSmall-CapFundamental AnalysisHealthcareScore DistributionCash RunwayPre-RevenueData Analysis2026

We Scored 313 Small-Cap Biotechs — 80% Score Below 50. Here's Why That's Correct.

Of 313 small-cap biotechs in our universe, 80% score below 50 and only 7% score 70+. That looks like a model failure. It isn't — the screen is correctly flagging pre-revenue binary-outcome risk. The data, the 7% that pass, and what it means for your watchlist.

Surgical RoboticsMedical DevicesHealthcareSmall-CapSector AnalysisMay 2026

4 Best Small-Cap Surgical Robotics & Med-Device Stocks — May 2026

Pure-play surgical robotics small-caps are rare. The actual investable layer is robotics-adjacent specialty surgical devices: ablation, nerve repair, sleep-apnea implants. 5 names with capital-equipment-plus-recurring-consumables economics.

biotechhealthcaresmall-capsector analysis

7 Best Small-Cap Biotech Stocks for 2026 (Cash + Pipeline)

7 small-cap biotech stocks ranked on cash runway, pipeline depth, and balance sheet. April 2026 data — see which are trading below cash.

fda approvalsmall-caphealthcarebiotechstock analysis

BrainSway (BWAY): FDA Clears At-Home Deep TMS

BrainSway (BWAY) gets FDA clearance for at-home Deep TMS depression therapy. Revenue impact, TAM, and our fundamental score breakdown.

HealthcareSmall-CapScore AnalysisDeep Dive

5 Best Small-Cap Healthcare Stocks for 2026 (Ranked)

5 small-cap healthcare stocks scoring 88+/100 for 2026. Revenue growth, margins, and risk analysis per pick — ranked on 8 fundamental metrics.

HealthcareSector AnalysisMarket Analysis

Healthcare Small-Cap Sector Analysis 2026 — Top 5

Healthcare dominates top-scoring small-caps in 2026. Sub-sector breakdown, top 5 picks, and the key metrics separating winners from burnouts.